Lipopolysaccharide (LPS) is a crucial constituent of the outer membrane of most Gram-
negative bacteria, playing a fundamental role in the protection of bacteria from …

Systemic inflammation is associated with chronic disease and is purported to be a main
pathogenic mechanism underlying metabolic conditions. Microbes harbored in the host …

Lipopolysaccharide (LPS), also referred to as endotoxin, is the major component of Gram-
negative bacteria's outer cell wall. It is one of the main types of pathogen-associated …

The synergy of living microbial and small-molecular therapeutics has been widely explored
for treating a variety of diseases, while current combination strategies often suffer from low …

Glycans are involved in various life processes and represent critical targets of biomedical
developments. Nevertheless, the accessibility to long glycans with precise structures …

Hyperlipidemia is a risk factor and key indicator for cardiovascular diseases, and the gut
microbiota is highly associated with hyperlipidemia. Bacteroides vulgatus is a prevalent …

The cell-envelope of Gram-negative bacteria contains endotoxic lipopolysaccharides (LPS)
that are recognized by the innate immune system via Toll-Like Receptors (TLRs). The …

Backgrounds Glucagon-like peptide-1 receptor agonist (GLP-1 RA) is probably one of more
effective antidiabetic agents in treatment of type 2 diabetes mellitus (T2D). However, the …

Covering: 2014 to June 2022 The gut microbiota has attracted increasing attention from
researchers due to its critical role in regulating human physiology and pathophysiology …

Lipopolysaccharides (LPS) are the main components of the external leaflet of the Gram-
negative outer membrane and consist of three different moieties: lipid A, core …